Group One Trading’s Arcadia Biosciences RKDA Stock Holding History

Group One Trading’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25	Hold	18	–	–	﹤0.01%	7459
2025 Q4	$36	Hold	18	–	–	﹤0.01%	7946
2025 Q3	$62	Hold	18	–	–	﹤0.01%	8259
2025 Q2	$79	Hold	18	–	–	﹤0.01%	7793
2025 Q1	$51	Hold	18	–	–	﹤0.01%	7426
2024 Q4	$107	Hold	18	–	–	﹤0.01%	7096
2024 Q3	$50	Hold	18	–	–	﹤0.01%	6498
2024 Q2	$57	Hold	18	–	–	﹤0.01%	6569
2024 Q1	$39	Hold	18	–	–	﹤0.01%	6874
2023 Q4	$55	Hold	18	–	–	﹤0.01%	7225
2023 Q3	$60	Sell	18 -86	-83%	-$352	﹤0.01%	7497
2023 Q2	$404	Hold	104	–	–	﹤0.01%	7391
2023 Q1	$777	Sell	104 -54	-34%	-$573	﹤0.01%	6835
2022 Q4	$1.71K	Sell	158 -75	-32%	-$1.07K	﹤0.01%	6699
2022 Q3	$5K	Buy	233 +225	+2,813%	+$7.67K	﹤0.01%	6847
2022 Q2	$0	Sell	8 -394	-98%	-$18.1K	﹤0.01%	8414
2022 Q1	$23K	Buy	+402	New	+$19.2K	﹤0.01%	6671

Other funds holding RKDA

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Group One Trading's RKDA Position: Q1 2026 in Review

Group One Trading held its Arcadia Biosciences (RKDA) position steady in Q1 2026 at 18 shares worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #7459.

Group One Trading first reported a position in RKDA in Q1 2022 and has held it in 17 quarters since. The position peaked at $23K in Q1 2022. 16 funds tracked by Wall St. Rank hold RKDA as of Q1 2026.

Group One Trading held 18 shares of Arcadia Biosciences worth $25 as of Q1 2026.
Group One Trading left its Arcadia Biosciences share count unchanged in Q1 2026.
Arcadia Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7459 holding.
Group One Trading first reported a position in Arcadia Biosciences in Q1 2022 and has held it in 17 quarters since.
Group One Trading's Arcadia Biosciences position peaked at $23K in Q1 2022.
16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.